Drug Report History #72666
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v16-FR | Version v7-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated (Changed) | Updated to: 2021-08-11 | Was: 2019-07-04 |
| Drug Identification Number | 02393018 | 02393018 |
| Brand name | MINT-IRBESARTAN/HCTZ | MINT-IRBESARTAN/HCTZ |
| Common or Proper name | Irbesartan HCTZ | Irbesartan HCTZ |
| Company Name | MINT PHARMACEUTICALS INC | MINT PHARMACEUTICALS INC |
| Ingredients | HYDROCHLOROTHIAZIDE IRBESARTAN | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 12.5MG 300.0MG | 12.5MG 300.0MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 100 count bottles | 100 count bottles |
| Additional packaging sizes | ||
| ATC code | C09DA | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2019-01-03 | 2019-01-03 |
| Estimated end date (Changed) | Updated to: 2020-06-30 | Was: 2019-09-30 |
| Actual end date (Changed) | Updated to: 2020-07-08 | Was: |
| Shortage status (Changed) | Updated to: Resolved | Was: Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |